Yubo Zhou
Jiangnan University(CN)Nanjing University of Chinese Medicine(CN)Ningbo University of Technology(CN)Beijing University of Chinese Medicine(CN)Shanghai Jiao Tong University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Sciences(CN)Peking University(CN)National Health and Family Planning Commission(CN)Beijing Institute of Genomics(CN)Kavli Institute for Particle Astrophysics and Cosmology(US)Zhejiang Cancer Hospital(CN)Shanghai Institute of Materia Medica(CN)National Center for Drug Screening(CN)Drug Discovery Laboratory (Norway)(NO)Peking University Third Hospital(CN)University of Chinese Academy of Sciences(CN)State Key Laboratory of Drug ResearchOcean University of China(CN)Hainan Tropical Ocean University(CN)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, Peptidase Inhibition and Analysis, Protein Tyrosine Phosphatases
Most-Cited Works
- → A systematic analysis of FDA-approved anticancer drugs(2017)318 cited
- → Selective Late‐Stage Oxygenation of Sulfides with Ground‐State Oxygen by Uranyl Photocatalysis(2019)239 cited
- → SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target(2021)188 cited
- → Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s–PPARα axis signalling(2014)154 cited
- → Rubiyunnanins C–H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation(2010)97 cited
- → Oncogenes and tumor suppressor genes: comparative genomics and network perspectives(2015)87 cited